ANRO
NYSE · Pharmaceuticals
Alto Neuroscience Inc
$30.76
+0.13 (+0.42%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
-27.9% upside
Low Target
$14.63
Average Target
$22.17
High Target
$27.87
Current Price
$30.76
Current
$30.76
$30.76
Target
$22.17
$22.17
$14.63
$22.17 avg
$27.87
Scenario Analysis
Bear Case
$14.63
-52.4%
Low target
Base Case
$22.17
-27.9%
Avg target
Bull Case
$27.87
+-9.4%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$37.48
-17.9% from high
52-Week Low
$3.59
+756.8% from low
Target vs 52W High
$22.17
-40.8% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +14.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.2% |
| MRK | Buy | 36 | 72% | $159.27 | +6.5% |
| PFE | Hold | 36 | 39% | $33.90 | +22.2% |
| BMY | Hold | 35 | 43% | $174.50 | +178.7% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +194.2% |